Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Myopia, Pathological

3,4-dihydroxyphenylacetic acid has been researched along with Myopia, Pathological in 1 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
van der Sande, E1
Polling, JR1
Tideman, JWL1
Meester-Smoor, MA1
Thiadens, AAHJ1
Tan, E1
De Zeeuw, CI1
Hamelink, R1
Willuhn, I1
Verhoeven, VJM1
Winkelman, BHJ1
Klaver, CCW1

Other Studies

1 other study available for 3,4-dihydroxyphenylacetic acid and Myopia, Pathological

ArticleYear
Myopia control in Mendelian forms of myopia.
    Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists), 2023, Volume: 43, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Atropine; Disease Progression; Female; Humans; Male; Mice;

2023